Literature DB >> 15021955

[Desflurane in acute intermittent porphyria].

M Messmer1, F Gerheuser, H Forst.   

Abstract

Despite the low incidence of the acute porphyrias, a profound knowledge of the disease is essential for anaesthesiologists, as a variety of perioperatively administered drugs are potential triggers of an acute attack. There is an ongoing discussion about the use of volatile anaesthetics in porphyrias, but halothane and isoflurane seem to be safe. There is no clinical data or case report about the use of desflurane in this specific patient group, but its fast and relatively unchanged elimination and the minimal induction of the cytochrome P 450 system seem to be favorable in this setting. We report the use of desflurane in a patient with acute intermittent porphyria, scheduled for hemihepatectomy. To minimize perioperative distress by pain or the need for postoperative mechanical ventilation, we chose a balanced anaesthesia technique with desflurane, sufentanil and atracurium in combination with a continuous epidural analgesia (bupivacain and fentanyl) for the postoperative period. Preoperatively the porphyrin precursors were analyzed in serum and urine and postoperatively the 24 h-urine was screened every 2 days until postoperative day 6 to monitor the porphyria activity. The preoperative data showed high concentrations of porphyrin precursor excretion, confirming the diagnosis of AIP. The postoperative data in the 24 h-urine were significantly lower than preoperative levels and reached normal levels at postoperative day 5. There were no clinical symptoms of a porphyric attack during the postoperative hospitalization. The patient was discharged on postoperative day 21 in excellent condition. We conclude that our perioperative management prevented an acute porphyric attack in this case. Desflurane might be a valuable alternative to other hypnotics in patients with AIP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021955     DOI: 10.1007/s00101-003-0615-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  22 in total

Review 1.  Porphyrias.

Authors:  M F James; R J Hift
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

2.  Porphyria and propofol.

Authors: 
Journal:  Anaesthesia       Date:  1989-07       Impact factor: 6.955

3.  Anaesthesia for porphyria using propofol.

Authors:  R Cooper
Journal:  Anaesthesia       Date:  1988-07       Impact factor: 6.955

4.  Safe use of propofol in a patient with acute intermittent porphyria.

Authors:  G Mitterschiffthaler; A Theiner; H Hetzel; L C Fuith
Journal:  Br J Anaesth       Date:  1988-01       Impact factor: 9.166

Review 5.  Anaesthesia for the porphyric patient.

Authors:  G G Harrison; P N Meissner; R J Hift
Journal:  Anaesthesia       Date:  1993-05       Impact factor: 6.955

Review 6.  Neurologic manifestations of acute porphyria.

Authors:  H L Bonkowsky; W Schady
Journal:  Semin Liver Dis       Date:  1982-05       Impact factor: 6.115

7.  Measles notifications -- the first year.

Authors:  I H Gibson; T R Carmichael; H G Küstner
Journal:  S Afr Med J       Date:  1982-01-16

8.  Effect of certain anaesthetic agents on the activity of rat hepatic delta-aminolaevulinate synthase.

Authors:  R K Parikh; M R Moore
Journal:  Br J Anaesth       Date:  1978-11       Impact factor: 9.166

Review 9.  Management of attacks of acute porphyria.

Authors:  A C Laiwah; K E McColl
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

10.  Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane.

Authors:  T S Sutton; D D Koblin; L D Gruenke; R B Weiskopf; I J Rampil; L Waskell; E I Eger
Journal:  Anesth Analg       Date:  1991-08       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.